Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/3/2009

facilities, products and/or business; uncertainties and risks related to the scope, validity, and enforceability of patents related to ISTA's products and technologies and the impact of patents and other intellectual property rights held by third parties; and such other risks and uncertainties as detailed from time to time in ISTA's public filings with the U.S. Securities and Exchange Commission, including but not limited to ISTA's Annual Report on Form 10-K for the year ended December 31, 2008 and ISTA's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2009, and June 30, 2009.

                             ISTA Pharmaceuticals, Inc.
                     Consolidated Statements of Operations
                      (in thousands, except per share data)
                                   (unaudited)

                                     Three Months Ended   Nine Months Ended
                                        September 30,       September 30,
                                       2009      2008      2009      2008
                                               Adjusted           Adjusted
    Revenue:
      Product sales, net             $29,080   $21,604   $73,309   $54,749
      License revenue                  2,917        69     3,055       208
                                     -------   -------   -------   -------
    Total revenue                     31,997    21,673    76,364    54,957
    Cost of products sold              7,304     5,806    18,647    14,761
                                     -------   -------   -------   -------
    Gross profit margin               24,693    15,867    57,717    40,196
    Costs and expenses:
      Research and development         6,257     7,766    19,643    25,053
      Selling, general, and
       administrative                 13,187    13,198    38,874    40,150
                                     -------   -------   -------   -------
    Total costs and expenses          19,444    20,96
'/>"/>
SOURCE  ISTA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 (PRWEB) June 18, 2013 ... and attendance system in North America, has introduced ... employee data and payroll records between ExakTime’s software ... automates ExakTime software setup and keeps employee ... employee data from a business’ current payroll software, ...
(Date:6/18/2013)... DuPont welcomes 48 of the nation’s finest ... AgriScience Teachers Ambassador Academy this week (NATAA) at the ... , The NATAA “Ag Academy” is a professional ... project of the National FFA Foundation and ... The highly recommended agriscience teachers, who are participating ...
(Date:6/18/2013)... -- regulated information — Global biopharmaceutical company UCB, Inc. and ... launch of a new Pledge campaign for people with ... empowers the millions of Americans living with ... commitment to demand more: greater understanding of the condition, ... partial-onset seizure control.  More information is available at ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
Breaking Biology Technology:ExakTime Introduces AccountLinx Plus 2DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading ... that effective on March 16, 2009 the exercise term ... the holder to purchase one Class A common share ... extended from March 23, 2009 to December 31, 2009. ...
... Food Processing, Industry,VANCOUVER, March 2 ... "the Company") today announced that it has completed ... dehydration equipment to CAL-SAN Enterprises, Ltd. of Richmond, ... With this sale, EnWave has proven that it ...
... Part of "In the Zone for UC" Campaign, Centocor ... & Colitis Foundation of America for Each Point Pisani ... Centocor Ortho Biotech Inc. announced today a partnership with ... ulcerative colitis (UC) and funding to support continued education ...
Cached Biology Technology:BioMS Medical warrant extension 2EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 2EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 3EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 4Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis 2Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis 3Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis 4
(Date:6/18/2013)... June 19, 2013  Paris Air Show – ... Test Systems) , a leading provider of innovative ... is demonstrating its solutions this week at the ... With growing challenges including increasingly complex armament systems ... feature-rich, specialized aerospace test solutions that address legacy ...
(Date:6/18/2013)... been awarded a $394,300 grant from the Tarrant ... flow in the new facilities of the 150-mile ... associate professor of civil engineering, will investigate the ... the water in an effort to eliminate biological ... Adding monochloramine is widely practiced throughout the United ...
(Date:6/18/2013)... Laboratory of Molecular Biology, has been honored as ... Award. Torrent is being recognized for his outstanding ... predict antimicrobial regions in proteins. Luis Rivas, Centro ... this algorithm to interrogate full genomes in order ... appealing results." , Torrent obtained his Ph.D. ...
Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2The American Society for Microbiology honors Marc Torrent 2
... Understanding the tens of thousands of proteins that compose the ... century, and research efforts to date have already enabled major ... potential avenues have been blocked by lack of information about ... bulk of these so far enigmatic proteins may now be ...
... Displays, Without Sacrificing Display Viewing QualityTHE WOODLANDS, Texas, ... UNXL), the developer of a unique new thin ... announced the availability of test samples for customers. ... to produce a transparent protective cover film that ...
... University of Pennsylvania has completed a research study begun in ... the northwest Atlantic Ocean around Mount Desert Island, Me., has ... during less than a century, providing a clear illustration of ... is published in the current issue of the Proceedings ...
Cached Biology News:New high-throughput screening technique makes probing puzzling proteins possible 2New high-throughput screening technique makes probing puzzling proteins possible 3New high-throughput screening technique makes probing puzzling proteins possible 4New high-throughput screening technique makes probing puzzling proteins possible 5UniPixel Announces Availability of Opcuity(TM) Finger Print Resistant Film Test Samples 2UniPixel Announces Availability of Opcuity(TM) Finger Print Resistant Film Test Samples 3Penn biologists demonstrate that size matters... in snail shells 2Penn biologists demonstrate that size matters... in snail shells 3
...
GLP expression profiling service on the Affymetrix platform. Starting material can be blood, tissue or RNA. 5 day turnaround. Standard and custom post analyses of microarray data available....
... Service enables early selection of the ... providing quantitative data for sensitivity, dynamic ... antibody. Furthermore quantitative antibody fingerprints can ... of your antibodies., The full-service package ...
... kit allows for rapid, convenient, and efficient ... bind/wash/elute process utilizes a spin column to ... for concentration of proteins which were electro-eluted ... strong ion exchangers, offering high binding capacity ...
Biology Products: